Oncolytics Biotech (ONCY) Reports In-Line Q2 EPS
Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.
Oncolytics Biotech (NASDAQ: ONCY) reported Q2 EPS of ($0.10), in-line with the analyst estimate of ($0.10).
For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.